EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Association between Serum Prolactin Levels and Neurodegenerative Diseases: Systematic Review and Meta-Analysis

Hai Duc Nguyen, Ngoc Minh Hong Hoang, Myeonghee Ko, Dongjin Seo, Shinhyun Kim, Won Hee Jo, Jung-Woo Bae, Min-Sun Kim

Neuroimmunomodulation · 2022 · 29 (2) · 85-96

DOI: 10.1159/000519552 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Neuroimmunomodulation, online erschienen am 20.10.2021. Verfasst von Hai Duc Nguyen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, Suncheon, Republ…. Hauptthemen laut MEDLINE: Multiple Sclerosis, Neurodegenerative Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 78 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Prolactin (PRL) exerts inflammatory and anti-inflammatory properties and is also thought to play an important role in the pathogenesis of neurodegenerative diseases (NDs). However, serum PRL levels in patients with NDs were inconsistent in the research literature.

Objective

We aimed to assess the serum PRL levels in patients with NDs.

Methods

Electronic databases, including MEDLINE, Embase, Cochrane Library database, clinicaltrials.gov, Web of Science, and Google Scholar, and reference lists of articles were searched up to December 31, 2020. Pooled standard mean difference (SMD) with 95% confidence interval (CI) was calculated by fixed-effect or random-effect model analysis.

Results

A total of 36 comparisons out of 29 studies (3 RCTs and 26 case controls) focusing on NDs (including Parkinson’s disease, Alzheimer’s disease, Huntington’s disease [HD], multiple sclerosis [MS], and epilepsy) were reported. The meta-analysis showed that there was no statistically significant difference in serum PRL levels between patients with NDs and healthy controls (SMD = 0.40, 95% CI: −0.16 to 0.96, p = 0.16). Subgroup analysis showed that serum PRL levels in patients with HD and MS were higher than those of healthy controls. Furthermore, patients with NDs aged

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisNeurodegenerative DiseasesCase-Control StudiesHumansMiddle AgedProlactin

Stichwörter der Autor:innen

Alzheimer’s diseaseHuntington diseaseMultiple sclerosisParkinson’s diseaseProlactin

Substanzen

Prolactin

Autor:innen und Institutionen

  • Department of Pharmacy, College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, Suncheon, Republic of Korea.
  • College of Pharmacy, Keimyung University, Daegu, Republic of Korea.

Zitieren

APA

Duc Nguyen, H., Hoang, N. M. H., Ko, M., Seo, D., Kim, S., Jo, W. H., Bae, J. W., & Kim, M. S. (2022). Association between Serum Prolactin Levels and Neurodegenerative Diseases: Systematic Review and Meta-Analysis. Neuroimmunomodulation, 29(2), 85-96. https://doi.org/10.1159/000519552

Vancouver

Duc Nguyen H, Hoang NMH, Ko M, Seo D, Kim S, Jo WH, et al. Association between Serum Prolactin Levels and Neurodegenerative Diseases: Systematic Review and Meta-Analysis. Neuroimmunomodulation. 2022;29(2):85-96. doi:10.1159/000519552

BibTeX
@article{DucNguyen2022,
  author = {Duc Nguyen, Hai and Hoang, Ngoc Minh Hong and Ko, Myeonghee and Seo, Dongjin and Kim, Shinhyun and Jo, Won Hee and Bae, Jung-Woo and Kim, Min-Sun},
  title = {Association between Serum Prolactin Levels and Neurodegenerative Diseases: Systematic Review and Meta-Analysis},
  journal = {Neuroimmunomodulation},
  year = {2022},
  volume = {29},
  number = {2},
  pages = {85--96},
  doi = {10.1159/000519552}
}
Kostenlos starten →